United States · FDA National Drug Code directory
Lisinopril and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-045_1adb1ec1-dcf6-4f50-8e0e-cdf58c2d84c2
- Product NDC
- 65862-045
- Form
- TABLET
- Composition / generic term
- Lisinopril and Hydrochlorothiazide
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20060314
- Source listing expiry
- 20271231
Source-listed ingredients
- LISINOPRIL — 20 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (65862-045-00) · 65862-045-00
- 100 TABLET in 1 BOTTLE (65862-045-01) · 65862-045-01
- 500 TABLET in 1 BOTTLE (65862-045-05) · 65862-045-05
- 30 TABLET in 1 BOTTLE (65862-045-30) · 65862-045-30
- 1000 TABLET in 1 BOTTLE (65862-045-99) · 65862-045-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →